136 related articles for article (PubMed ID: 27678127)
41. Sex and Race-Ethnic Disparities in Door-to-CT Time in Acute Ischemic Stroke: The Florida Stroke Registry.
Polineni SP; Perez EJ; Wang K; Gutierrez CM; Walker J; Foster D; Dong C; Asdaghi N; Romano JG; Sacco RL; Rundek T;
J Am Heart Assoc; 2021 Apr; 10(7):e017543. PubMed ID: 33787282
[TBL] [Abstract][Full Text] [Related]
42. Improving door-to-needle times: a single center validation of the target stroke hypothesis.
Ruff IM; Ali SF; Goldstein JN; Lev M; Copen WA; McIntyre J; Rost NS; Schwamm LH
Stroke; 2014 Feb; 45(2):504-8. PubMed ID: 24399372
[TBL] [Abstract][Full Text] [Related]
43. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
Moran JL; Nakagawa K; Asai SM; Koenig MA
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
[TBL] [Abstract][Full Text] [Related]
44. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors.
Van Schaik SM; Scott S; de Lau LM; Van den Berg-Vos RM; Kruyt ND
Cerebrovasc Dis Extra; 2015; 5(2):75-83. PubMed ID: 26265910
[TBL] [Abstract][Full Text] [Related]
45. Factors associated with in-hospital delays in treating acute stroke with intravenous thrombolysis in a tertiary centre.
Iglesias Mohedano AM; García Pastor A; García Arratibel A; Sobrino García P; Díaz Otero F; Romero Delgado F; Domínguez Rubio R; Muñoz González A; Vázquez Alen P; Fernández Bullido Y; Villanueva Osorio JA; Gil Núñez A
Neurologia; 2016 Sep; 31(7):452-8. PubMed ID: 25660140
[TBL] [Abstract][Full Text] [Related]
46. Impact of Emergency Department Crowding on Delays in Acute Stroke Care.
Jaffe TA; Goldstein JN; Yun BJ; Etherton M; Leslie-Mazwi T; Schwamm LH; Zachrison KS
West J Emerg Med; 2020 Jul; 21(4):892-899. PubMed ID: 32726261
[TBL] [Abstract][Full Text] [Related]
47. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
[TBL] [Abstract][Full Text] [Related]
48. Creation of an intensive care unit and organizational changes in an adult emergency department: Impact on acute stroke management.
Puy L; Lamy C; Canaple S; Arnoux A; Laine N; Iacob E; Constans JM; Godefroy O
Am J Emerg Med; 2017 May; 35(5):716-719. PubMed ID: 28096032
[TBL] [Abstract][Full Text] [Related]
49. Older Stroke Patients with High Stroke Scores Have Delayed Door-To-Needle Times.
Birnbaum LA; Rodriguez JS; Topel CH; Behrouz R; Misra V; Palacio S; Patterson MG; Motz DS; Goros MW; Cornell JE; Caron JR
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2668-2672. PubMed ID: 27476342
[TBL] [Abstract][Full Text] [Related]
50. Meet Me in Computed Tomography Suite: Decreasing Tissue Plasminogen Activator Door-to-Needle Time for Acute Ischemic Stroke Patients.
Speirs L; Mitchell A
J Emerg Nurs; 2015 Sep; 41(5):381-6. PubMed ID: 25794980
[No Abstract] [Full Text] [Related]
51. Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.
Sauser Zachrison K; Levine DA; Fonarow GC; Bhatt DL; Cox M; Schulte P; Smith EE; Suter RE; Xian Y; Schwamm LH
Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28283469
[TBL] [Abstract][Full Text] [Related]
52. Drill down analysis of door-to-needle time of acute ischemic stroke patients treated with intravenous tissue plasminogen activator.
Schrock JW; Lum M
Am J Emerg Med; 2014 Nov; 32(11):1330-3. PubMed ID: 25195044
[TBL] [Abstract][Full Text] [Related]
53. Thrombolysis candidates for the treatment of stroke at an emergency department in Japan.
Yamaguchi K; Hori S; Nogawa S; Tanahashi N; Fukuuchi Y; Aikawa N
Acad Emerg Med; 2002 Jul; 9(7):754-8. PubMed ID: 12093719
[TBL] [Abstract][Full Text] [Related]
54. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.
Rost NS; Smith EE; Pervez MA; Mello P; Dreyer P; Schwamm LH
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):314-20. PubMed ID: 22534407
[TBL] [Abstract][Full Text] [Related]
55. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital.
Szoeke CE; Parsons MW; Butcher KS; Baird TA; Mitchell PJ; Fox SE; Davis SM
Med J Aust; 2003 Apr; 178(7):324-8. PubMed ID: 12670274
[TBL] [Abstract][Full Text] [Related]
56. Impact of a code stroke protocol on the door-to-needle time for IV thrombolysis: a feasibility study.
Vanhoucke J; Hemelsoet D; Achten E; De Herdt V; Acou M; Vereecke E; Hachimi-Idrissi S
Acta Clin Belg; 2020 Aug; 75(4):267-274. PubMed ID: 31081471
[TBL] [Abstract][Full Text] [Related]
57. Frequent Hub-Spoke Contact Is Associated with Improved Spoke Hospital Performance: Results from the Massachusetts General Hospital Telestroke Network.
Moreno A; Schwamm LH; Siddiqui KA; Viswanathan A; Whitney C; Rost N; Zachrison KS
Telemed J E Health; 2018 Sep; 24(9):678-683. PubMed ID: 29271703
[TBL] [Abstract][Full Text] [Related]
58. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
[TBL] [Abstract][Full Text] [Related]
59. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
[TBL] [Abstract][Full Text] [Related]
60. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
